The hybrid operating room. Should one be available for cardiovascular-thoracic procedures in the MUHC? A brief report
McGregor M
Record ID 32013000293
English
Authors' objectives:
To assemble the technological and cost data pertinent to this decision.
Authors' recommendations:
Our CVT surgeons believe that without access to a hybrid OR they will increasingly be unable to deliver optimal patient care in the future.
There is no objective scientific evidence bearing on the health benefits to be expected from use of a hybrid OR for CVT procedures (Note: The absence of such evidence in no way indicates that such a facility would not result in better health care).
The cost (annualised capital cost plus maintenance plus operation) of a hybrid OR for CVT would be approximately $410,000 per year. In terms of opportunity cost, this is equivalent to the annual cost of 3.1 acute surgical beds. (Assuming a cost of $360 per day [N Robert].)
There is at present no need for a hybrid OR to accommodate overflow from Cardiology. The present and planned cardiac catheterisation laboratories have a capacity that can cope with both the present and the anticipated maximum future demand for TAVIs and mitral procedures.
The new hybrid OR allocated to Vascular Surgery will be approximately 65% occupied with vascular procedures. [O Steinmetz]. The possibility of negotiating a sharing agreement to accommodate CVT could be explored.
Unless the nursing contract can be revised it will not be possible to carry out surgical interventions in the catheterisation laboratory at the new hospital site.
Details
Project Status:
Completed
Year Published:
2012
URL for published report:
http://www.mcgill.ca/tau/files/tau/muhc_tau_2012_67_hybrid.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Hospital Design and Construction
- Surgery, Computer-Assisted
Contact
Organisation Name:
Technology Assessment Unit of the McGill University Health Centre (MUHC)
Contact Address:
Technology Assessment Unit of the MUHC, Centre for Outcomes Research and Evaluation (CORE), Research Institute of the McGill University Health Centre, 5252 boul. de Maisonneuve, Bureau 3F.50, Montreal, Quebec H4A 3S5
Contact Name:
nandini.dendukuri@mcgill.ca
Contact Email:
nandini.dendukuri@mcgill.ca
Copyright:
Technology Assessment Unit of the McGill University Health Centre (MUHC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.